The markets closed flat with the Dow slipping 8 points to 20,905 after FBI director James Comey testified that there was no evidence to support President Donald Trump's claim that his campaign offices were wiretapped by former President Barack Obama. Nasdaq held steady at 5,901.
On the upside
Aurinia Pharmaceuticals (Nasdaq: AUPH) closed its public offering of approximately 25.6 million common shares.
Dominion Diamond (NYSE: DDC) has rejected the conditions imposed by Washington Cos. to hold acquisition discussions.
CytomX Therapeutics (Nasdaq: CTMX) expanded its collaboration agreement with Bristol-Myers Squibb and will receive a $200 million upfront payment to develop cancer treatments using CytomX's Probody platform.
On the downside
Shares of Top Ships (Nasdaq: TOPS) extended its losses.
Profit taking weighed down shares of Pulmatrix (Nasdaq: PULM).
QuickLogic (Nasdaq: QUIK) announced a public offering of $15 million in common shares.
In the broad market, declining issues outpaced advancers by a margin of 7 to 5 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index lost 4 points to 2,373. Bitcoin slipped $1 to $1,045.
